Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

NCT05806164 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

432

Enrollment

OTHER

Sponsor class

Conditions

Urgency Urinary Incontinence

Interventions

DRUG: Beta3-Agonists, Adrenergic [Mirabegron/Vibegron]
DRUG: OnabotulinumtoxinA 100 UNT [Botox]

Sponsor

Women and Infants Hospital of Rhode Island

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]